South Korea
Also, Neurophet will tap into Roche's data to further improve its brain scan analysis AI.
Latest studies have demonstrated high AI accuracies in predicting cancer recurrence and spotting minor colon polyps.
Also, OMRON in Singapore has launched a new medical device plan featuring AI-driven recommendations for self-management of chronic diseases.
It can also predict the onset of Parkinson's motor symptoms.
Also, four tuberculosis screening AI solutions from Asia-Pacific are among those recommended by the World Health Organization.
A new study has looked into factors influencing doctors, chronically ill patients, and healthy persons to prefer one health application over another.
Also, a Taiwanese startup has received the US FDA's 510(k) clearance for its neurosurgical robot.
Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.
Also, fellow Korean medical AI companies have obtained regulatory approvals across global markets.
The model could be deployed as a decision support tool in emergency departments.